
Sahil Pradeep Mulaokar
About Sahil Pradeep Mulaokar
Data last updated:
Sahil Pradeep Mulaokar is a Director at Zephyr Speciality Chemicals Private Limited (since 2019), Director at Novel Molecules Private Limited (since 2019) and Designated Partner at Beta Molecules Llp (since 2022). The companies operate in Chemicals, Chemicals and Materials and Wood. The 2 current companies with reported revenue have a combined latest revenue of ₹4.35 Cr; the largest is Zephyr Speciality Chemicals Private Limited at ₹3.28 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Jan 2019 | 2018 | ₹3.28 Cr (FY 2020) | Active | |
| Director | 10 Dec 2019 | 2019 | ₹1.07 Cr (FY 2025) | Active | |
| Designated Partner | 28 Dec 2022 | 2022 | Active |
Board colleagues of Sahil Pradeep Mulaokar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradeep Digamber Mulaokar | 03048271 | Zephyr Speciality Chemicals Private Limited , Novel Molecules Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahil Pradeep Mulaokar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahil Pradeep Mulaokar
Sahil Pradeep Mulaokar currently holds 3 directorships: Zephyr Speciality Chemicals Private Limited (Director, since 28 Jan 2019, revenue ₹3.28 Cr (FY 2020)); Novel Molecules Private Limited (Director, since 10 Dec 2019, revenue ₹1.07 Cr (FY 2025)); Beta Molecules Llp (Designated Partner, since 28 Dec 2022).
Sahil Pradeep Mulaokar was first appointed on 28 Jan 2019 as Director at Zephyr Speciality Chemicals Private Limited. The most recent appointment on record is 28 Dec 2022 at Beta Molecules Llp.
The 2 current companies of Sahil Pradeep Mulaokar that report revenue have a combined latest revenue of ₹4.35 Cr: Zephyr Speciality Chemicals Private Limited ₹3.28 Cr (FY 2020); Novel Molecules Private Limited ₹1.07 Cr (FY 2025).
The current boards of Sahil Pradeep Mulaokar's companies include Pradeep Digamber Mulaokar (Zephyr Speciality Chemicals Private Limited).